These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9873628)

  • 1. Design and synthesis of a pyridone-based phosphotyrosine mimetic.
    Fu JM; Castelhano AL
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2813-6. PubMed ID: 9873628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.
    Kawahata N; Yang MG; Luke GP; Shakespeare WC; Sundaramoorthi R; Wang Y; Johnson D; Merry T; Violette S; Guan W; Bartlett C; Smith J; Hatada M; Lu X; Dalgarno DC; Eyermann CJ; Bohacek RS; Sawyer TK
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2319-23. PubMed ID: 11527723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.
    Tokonzaba E; Capelluto DG; Kutateladze TG; Overduin M
    Chem Biol Drug Des; 2006 Mar; 67(3):230-7. PubMed ID: 16611216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1.
    Furet P; Caravatti G; Denholm AA; Faessler A; Fretz H; García-Echeverría C; Gay B; Irving E; Press NJ; Rahuel J; Schoepfer J; Walker CV
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2337-41. PubMed ID: 11055351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides.
    Lee K; Zhang M; Liu H; Yang D; Burke TR
    J Med Chem; 2003 Jun; 46(13):2621-30. PubMed ID: 12801226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides.
    Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP
    J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of a beta-amino phosphotyrosyl mimetic suitably protected for peptide synthesis.
    Lee K; Zhang M; Yang D; Burke TR
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3399-401. PubMed ID: 12419370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.
    Sundaramoorthi R; Kawahata N; Yang MG; Shakespeare WC; Metcalf CA; Wang Y; Merry T; Eyermann CJ; Bohacek RS; Narula S; Dalgarno DC; Sawyer TK
    Biopolymers; 2003; 71(6):717-29. PubMed ID: 14991680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered SH2 Domains for Targeted Phosphoproteomics.
    Martyn GD; Veggiani G; Kusebauch U; Morrone SR; Yates BP; Singer AU; Tong J; Manczyk N; Gish G; Sun Z; Kurinov I; Sicheri F; Moran MF; Moritz RL; Sidhu SS
    ACS Chem Biol; 2022 Jun; 17(6):1472-1484. PubMed ID: 35613471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphotyrosyl mimetics in the development of signal transduction inhibitors.
    Burke TR; Lee K
    Acc Chem Res; 2003 Jun; 36(6):426-33. PubMed ID: 12809529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder.
    Bian Y; Li L; Dong M; Liu X; Kaneko T; Cheng K; Liu H; Voss C; Cao X; Wang Y; Litchfield D; Ye M; Li SS; Zou H
    Nat Chem Biol; 2016 Nov; 12(11):959-966. PubMed ID: 27642862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 2.
    Walker CV; Caravatti G; Denholm AA; Egerton J; Faessler A; Furet P; García-Echeverría C; Gay B; Irving E; Jones K; Lambert A; Press NJ; Woods J
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2343-6. PubMed ID: 11055352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
    Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
    Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics.
    Jiang S; Li P; Peach ML; Bindu L; Worthy KW; Fisher RJ; Burke TR; Nicklaus M; Roller PP
    Biochem Biophys Res Commun; 2006 Oct; 349(2):497-503. PubMed ID: 16945340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphotyrosine isosteres: past, present and future.
    Cerulli RA; Kritzer JA
    Org Biomol Chem; 2020 Jan; 18(4):583-605. PubMed ID: 31777907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.